Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
about
Self-Assembled Bifunctional Peptide as Effective Drug Delivery Vector with Powerful Antitumor Activity.Nanoways to overcome docetaxel resistance in prostate cancer.Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy.A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approachNovel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cellsNanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?How nanotechnology can enhance docetaxel therapy.Synthesis, characterization and drug loading property of Monomethoxy-Poly(ethylene glycol)-Poly(ε-caprolactone)-Poly(D,L-lactide) (MPEG-PCLA) copolymers.A simple method to improve the stability of docetaxel micellesRecent advances in stealth coating of nanoparticle drug delivery systemsPaclitaxel drug delivery systems.Application of polysaccharides for surface modification of nanomedicines.PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.Drug Release by Direct Jump from Poly(ethylene-glycol-b-ε-caprolactone) Nano-Vector to Cell Membrane.Solubilization of flurbiprofen into aptamer-modified PEG-PLA micelles for targeted delivery to brain-derived endothelial cells in vitro.Polymeric micelles for multidrug delivery and combination therapy.A Novel MPEG-PDLLA-PLL Copolymer for Docetaxel Delivery in Breast Cancer Therapy.Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity.Antiangiogenic effect of docetaxel and everolimus as individual and dual-drug-loaded micellar nanocarriers.Polysialic acid and pluronic F127 mixed polymeric micelles of docetaxel as new approach for enhanced antitumor efficacy.Design, synthesis and biological evaluation for docetaxel-loaded brain targeting liposome with "lock-in" function.Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer.Design and evaluation of mPEG-PLA micelles functionalized with drug-interactive domains as improved drug carriers for docetaxel delivery.Development of a Rapid and Precise Reversed-phase High-performance Liquid Chromatography Method for Analysis of Docetaxel in Rat Plasma: Application in Single-dose Pharmacokinetic Studies of Folate-targeted Micelles Containing Docetaxel.Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma
P2860
Q33577737-92DB5E36-B77C-4FAC-A187-B6C7BCF97A69Q33909084-EA3C1CB2-FA7A-46DD-A295-7BBD4D516D8EQ35241553-07ECFF29-A33C-4674-989C-B918D5E879D6Q35617669-AA73B940-3535-475A-8A77-2B545FCE4C84Q35868357-DBF21555-D493-4F8B-A00D-FC18D1C60566Q35934052-1DA137D0-EB18-48FE-9327-D5BBD3142F08Q36860835-1A0F23C1-6C86-4CC1-B529-D45F489D71F1Q37091683-4A44AD44-F013-4C71-B934-DF14A05B97ACQ37291409-79BE5857-DA0B-40C7-9B8D-FACC1896BA99Q37408420-E10CB16F-0E39-4B16-8470-1938A0C59DCBQ37974590-95C39CAD-F2D4-429C-B640-A2173CF9D6A8Q38071668-C3AC0474-C830-4DE7-9ABE-00F5EAC70FBEQ38074443-C5A2D59A-5481-45FF-AA6E-534AAF2B3C47Q38677767-37AAB357-AD5A-406A-BB0E-6B401C15C7A4Q38695277-752E1E62-F9C7-413A-ABEC-EF752731C6C1Q38927345-F41673FB-89DB-4396-93A1-118248FE1277Q38981743-29268F35-7E48-4158-A77C-69EFBE242451Q39027223-01344734-97B5-4796-B3E4-98F9EF3302F0Q39131943-9F6110C6-928C-4899-9172-4B7E07884C0AQ39177694-3FC1700A-761C-48D6-86DC-B79DA911EC82Q39367399-AE72CC76-1A9C-4844-8E6B-9B7BCF8BBC46Q41430346-5B6300DC-667D-4D0E-B180-1ED4D6FA03EDQ42109453-53767BC8-7158-4392-B4B5-0F621E4E7DA2Q45995349-0F4255FA-74D2-4794-9E4F-8DA7A60E3B7EQ48731832-42785609-ED51-4491-9F6F-F862721CA8C5Q48822022-EDBC41A8-A5C3-404F-B488-76D0671DDF73Q50054796-8ECC299A-D160-4300-8B04-B8CEE3FDC426Q50866705-4EBFC4CE-FA15-4C41-B840-1358FD900F43Q55322247-DFDC5BAC-5CA7-49FE-9D97-219715998BD1Q58790015-ABEC9EE6-6373-458F-8179-B55C1902A8CE
P2860
Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Development of docetaxel-loade ...... polymer-based delivery system.
@en
Development of docetaxel-loade ...... polymer-based delivery system.
@nl
type
label
Development of docetaxel-loade ...... polymer-based delivery system.
@en
Development of docetaxel-loade ...... polymer-based delivery system.
@nl
prefLabel
Development of docetaxel-loade ...... polymer-based delivery system.
@en
Development of docetaxel-loade ...... polymer-based delivery system.
@nl
P2093
P1476
Development of docetaxel-loade ...... polymer-based delivery system.
@en
P2093
Chang-Hoon In
Chaul-Min Pai
Ji-Young Kim
Min-Hyo Seo
Min-Hyuk Yun
Sa-Won Lee
Seung Wei Jeong
Sun-Ok Kim
P304
P356
10.1016/J.JCONREL.2011.06.012
P407
P577
2011-06-24T00:00:00Z